Compounds, pharmaceutical ingredients, and processes for processing these compounds. 1. Help to treat chronic and acute allergic immune disorders: compound of formula (1) or acceptable salt of medicine in formula, where x is O-S (or) m -；And it is selected from the group consisting of: a) a link, -O-,- en...-N (R9) - o -N (COR9) -(b) Other formulas (2)；(c) Other formula (3)；(d) Other formula (4)；(e) Other formula (5)；If you are already registered, please log in first.-S- o -N (R) -This is... C.-N-；A 0, 1, 2 or 3； R is 0, 1 or 2； s is 0, 1 or 2； R is h, tar or halo tar； RA is independent h, halo, tar or halo tar； Rb is independent h, halo, tar or halo tar； R1 is heterogeneous, isopropene or isopropene； R2 is arilo, isopropene, isopropene, isopropyl or isopropene； R3 is - C (o) Oh o-n (H) - so2-rc； In the case that RC is asphalt, halogen tar, cyclopentadiene, arilo or isopropene； R4 is selected independently from asphalt Oh, halo, Alcoy, haloxy CN and halogen tar group； R8 is selected independently from group consisting of - CN, halo, tar, haloquilo, alcox, haloxy or cyclopentadiene； R9 is asphalt, Halogen, alcoxi,Among them: (1) the heteromorphic, isomerized or isomerized group in R1； and (2) each arilo, isomerized, tar or isomerized group R2 in R2； not replaced or replaced by 1 to 5 R5 groups selected from tar and alquenilo groups respectively, Asphalt, cyclopentadiene, cyclopentadiene, isopropene, isopropene, arilo, isopropene, halo, CN, sF5, osp5, NO2, ch2osi (R14) (R15) (R16),-OR14, -C (O) R14, -C (O) OR14, -O-C (O) -R14, -O-C (O) N (R14) (R15),-C (O) N (R14) (R15)-S (O) mR14 -S (O) pN (R14) (R15)- C (3DNOR14) R15 -N (R14) (R15)-N (R14) C (O) R15, -N (R14) S (O) pR15, -N (R14) S (O) pN (R15) (R16),-N (R14) C (O) N (R15) (R16) and -N (R14) C (O) OR16； or when a position is disubstituted with two R5 groups, the two R5 groups can form a cycloalkyl or heterocyclyl ring that is unsubstituted or substituted with 1 to 5 R6 groups and in which each of the alkyl, alkenyl,
